Hematologist
CION Cancer Clinics
Flow cytometry in blood cancer: what the result decides | CION Cancer Clinics
Flow cytometry names the type of abnormal cell. It reads the proteins on the surface of thousands of cells, which shows whether a leukaemia is myeloid or lymphoblastic, and whether a lymphoid cancer is B cell or T cell. That decides which treatment pathway fits. Later, it can look for tiny amounts of leukaemia left after treatment. This page explains what the report decides, and what it does not. At CION Cancer Clinics, our haematologist reviews abnormal blood reports with you, orders only the tests that answer your question and explains each result plainly.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does flow cytometry decide in a blood cancer?
- How does the test actually work?
- Which questions does flow cytometry answer?
- How is flow cytometry different from the other tests on your sample?
- How long does it take, and what can go wrong?
- What do families often misunderstand about flow cytometry?
- What can a flow cytometry report not tell you?
- Common questions about flow cytometry
The short answer
What does flow cytometry decide in a blood cancer?
Flow cytometry tells your team exactly what kind of cell the abnormal cells are. That decides the name of the blood cancer, such as acute myeloid or acute lymphoblastic leukaemia, and so it decides which treatment pathway you are placed on. It is also used later to look for tiny amounts of disease left after treatment.
Why the microscope is not enough
Under a microscope, many abnormal blood cells look alike. A blast from a myeloid leukaemia and a blast from a lymphoblastic leukaemia can be hard to tell apart by eye. Yet the two diseases are treated very differently. Flow cytometry reads the proteins on the surface of each cell, which act like a name badge. That badge shows which family the cell belongs to.
Where the sample comes from
It can be done on blood, on the liquid part of a marrow test, on fluid from around the lungs or spine, or on cells from a lymph node, a small gland that is part of the immune system. The sample must reach the laboratory fresh, because the cells need to be alive for the test to work well.
Your report may call this test immunophenotyping. It is the same thing: the phenotype is the cell's badge, and flow cytometry is the machine that reads it.Inside the laboratory
How does the test actually work?
Tagging the cells
The cells are mixed with antibodies, each built to stick to one surface protein. Each antibody carries a fluorescent dye of a different colour.
Single file past a laser
The cells flow one at a time through a narrow channel. A laser lights each one, and detectors record which colours glow and how brightly.
Thousands of cells in minutes
The machine reads many thousands of cells. That is far more than anyone could count by eye, which is why it can find small groups of abnormal cells.
A specialist reads the pattern
A haematopathologist groups cells with the same pattern and decides whether an abnormal group is present, what it is and how large it is.
Not sure whether this applies to you?
Ask an oncologistThe decisions
Which questions does flow cytometry answer?
Each answer changes something concrete about the plan.
Myeloid or lymphoid?
In an acute leukaemia, this separates AML from ALL. The two are treated with different medicines, schedules and supportive care.
B cell or T cell?
In ALL and lymphoma, it shows which type of lymphocyte is involved. This affects the treatment plan and which targeted medicines may fit.
Is it one abnormal family of cells?
Cancer cells come from a single cell, so they share one pattern. Flow cytometry can show this in chronic lymphocytic leukaemia and some lymphomas, which helps separate them from a reaction to infection.
How much is left after treatment?
Minimal residual disease, often written MRD, means leukaemia cells too few to see under a microscope. Very sensitive flow tests look for them. The result can change the next phase of treatment.
Also used in
- Myeloma, to count abnormal plasma cells
- PNH, a rare condition of red cells
Side by side
How is flow cytometry different from the other tests on your sample?
Test
The question it answers
Microscope smear
How many abnormal cells, and what do they look like?
Flow cytometry
What kind of cell are they, and how large is the abnormal group?
Karyotype and FISH
Are chromosomes broken, swapped or missing?
Gene panel (NGS or PCR)
Which specific gene changes are present?
Biopsy core with stains
How full is the marrow, and is there scarring?
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Practical matters
How long does it take, and what can go wrong?
Flow cytometry is one of the faster tests in the diagnostic set. A first report is often ready within a day or two of the sample reaching the laboratory, although this varies. Chromosome and gene tests usually take longer, so flow is often the first firm answer a family receives.
When the sample is not good enough
Cells start to die once they leave the body. A sample that sat too long, travelled in heat, clotted in the tube or was heavily diluted with blood can give a weak or unclear result. If your sample is being sent from a district to a laboratory in Hyderabad or further, ask how it will travel and how fast.
When the answer is unclear
Occasionally the cells carry badges from more than one family, or the abnormal group is very small. The report may then say "suggestive" or ask for correlation with other tests. That is honest reporting, not a failure. Your haematologist puts it together with the microscope, chromosome and gene results.
Commonly believed
What do families often misunderstand about flow cytometry?
"Flow cytometry is a genetic test."
It is not. It reads proteins on the surface of cells, not genes or chromosomes. Gene and chromosome tests are separate, and often both are needed.
"If flow cytometry is normal, there is no cancer."
A normal result is reassuring but does not rule everything out. Some cancers do not show well on flow, for example when cells are trapped in a scarred marrow or when Hodgkin lymphoma is the question. The biopsy may still be needed.
"A bigger abnormal percentage means a worse outlook."
The size of the abnormal group helps with the diagnosis. The outlook depends much more on the type of disease, its gene and chromosome changes, your health and how it responds to treatment.
"We can start treatment without it to save time."
In most blood cancers, knowing the exact cell type is what makes the treatment choice safe. Your haematologist decides what can start early, such as fluids or medicines to protect the kidneys.
Being straight with you
What can a flow cytometry report not tell you?
Flow cytometry names the cell type. It cannot, on its own, give the full risk group, choose the exact treatment or say what the future holds. Those depend on the chromosome and gene results, your age and fitness, and how the disease responds.
What to ask your haematologist
Ask what the abnormal cells were identified as, and how sure the laboratory is. Ask whether the result fits the microscope count. Ask which chromosome and gene tests are still pending and when to expect them. If MRD testing is planned later, ask whether a baseline pattern has been recorded now, because later tests compare against it.
How CION helps
Our haematology team reads the flow report with the rest of your results, presents the case to a tumour board, and coordinates testing and care with qualified laboratories and centres. If a test has to be sent out, we tell you where it is going and what it will answer.
Reporting styles differ between laboratories. Keep every original report, including the plots if they were given to you.Questions we are asked
Common questions about flow cytometry
Is flow cytometry done on blood or marrow?
Either, and sometimes both. If many abnormal cells are circulating, blood may be enough, for example in chronic lymphocytic leukaemia. For acute leukaemia, the marrow sample is usually preferred, because it gives a fuller picture and the same sample can go for chromosome and gene tests.
How long does a flow cytometry report take?
Often a day or two after the sample reaches the laboratory, though it depends on the laboratory and the panel being run. MRD tests after treatment can take longer. Ask your team when to expect it, and which other results will follow later.
What does "no immunophenotypic evidence of disease" mean?
It means the laboratory did not find an abnormal group of cells in the sample tested. That is reassuring. It applies to that sample and that test, so your haematologist still reads it with the microscope and other results before calling it clear.
What is MRD by flow?
MRD stands for minimal residual disease. After treatment, a very sensitive flow test looks for leukaemia cells too few to see under a microscope. A negative result is good news. A positive result may change the next step. Either way, it is one result among several.
Why did my report mention CD numbers?
CD numbers are the names of the surface proteins the test looks for, such as CD19 or CD33. The pattern of which ones are present shows the cell type. Our page on reading an immunophenotyping panel explains the common ones.
Can the sample be sent from our district?
Often, yes, but it must travel fast and in the right conditions, because the cells need to stay alive. Ask the collecting centre how it will be packed, who carries it and when it will reach the laboratory. A delayed sample can give an unclear result and need to be repeated.
Can flow cytometry diagnose lymphoma?
It helps with many lymphomas, especially when cells are in the blood, marrow or a fluid. For most lymphomas the diagnosis still rests on a biopsy of the lymph node or lump, read with stains. Hodgkin lymphoma in particular is usually diagnosed from tissue.
Is flow cytometry covered by insurance or schemes?
It is often covered when it is part of an approved diagnostic or treatment plan. Rules differ between Aarogyasri, CGHS, ECHS, EHS, PM-JAY and private insurers, and they change, so check the current rules for your card. Our helpline can check your cover with you.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Definition of flow cytometry
- American Cancer Society — Tests for Acute Lymphocytic Leukemia (ALL)
- American Cancer Society — Tests for Chronic Lymphocytic Leukemia
- National Cancer Institute — Definition of minimal residual disease
- Cancer Research UK — Acute lymphoblastic leukaemia (ALL)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Reading an Immunophenotyping PanelWhat the CD numbers on your report meanBlast Percentage: The Number That Defines the DiagnosisThe microscope count read alongside flowMinimal Residual Disease: The Number After TreatmentHow flow is used after treatmentKaryotype and FISH in Leukaemia: Why They Change TreatmentThe chromosome tests that follow
Talk to us
Waiting on a flow cytometry report?
Send it to us or call the helpline. Our haematology team will read it with you and explain which results are still to come.